MedPath
Found 5025 clinical trials|View Analysis
Sort by:

New Mechanisms of Obesity

Not Applicable
Not yet recruiting
Conditions
Obesity and Overweight
Insulin Resistance
First Posted Date
2025-01-10
Last Posted Date
2025-01-10
Lead Sponsor
Yale University
Target Recruit Count
55
Registration Number
NCT06768827
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects with Type 2 Diabetes Mellitus (T2DM)

Phase 3
Not yet recruiting
Conditions
Diabetes
Interventions
Drug: GZR4
Drug: Insulin Glargine U100
First Posted Date
2025-01-10
Last Posted Date
2025-01-10
Lead Sponsor
Gan & Lee Pharmaceuticals.
Target Recruit Count
580
Registration Number
NCT06767735

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects with Type 2 Diabetes Mellitus Treated with Basal Insulin

Phase 3
Not yet recruiting
Conditions
Diabetes
Interventions
First Posted Date
2025-01-10
Last Posted Date
2025-01-10
Lead Sponsor
Gan & Lee Pharmaceuticals.
Target Recruit Count
620
Registration Number
NCT06767748

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated with Basal + Prandial Insulin

Phase 3
Not yet recruiting
Conditions
Diabetes
Interventions
Drug: GZR4
Drug: Insulin Glargine U100 group
First Posted Date
2025-01-10
Last Posted Date
2025-01-10
Lead Sponsor
Gan & Lee Pharmaceuticals.
Target Recruit Count
580
Registration Number
NCT06767761

Assessment of Insulin Sensitivity in Healthy Adults by a 13C-glucose Breath Test : Method Development and Validation

Not Applicable
Completed
Conditions
Insulin Sensitivity/Resistance
First Posted Date
2025-01-09
Last Posted Date
2025-01-09
Lead Sponsor
Société des Produits Nestlé (SPN)
Target Recruit Count
7
Registration Number
NCT06766617
Locations
🇨🇭

Clinical innovation lab, Lausanne, Switzerland

Perioperative Glucose Monitoring and Treatment to Reduce Risk of Surgical Site Infections and Complications

Not Applicable
Conditions
Surgical Site Infections
Stress Hyperglycemia
Interventions
Drug: Insulin Lispro Injection
Diagnostic Test: glucose testing
First Posted Date
2025-01-09
Last Posted Date
2025-01-09
Lead Sponsor
St. Peter's Hospital, Albany, NY
Target Recruit Count
266
Registration Number
NCT06765655
Locations
🇺🇸

St. Peter's Hospital, Albany, New York, United States

Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy

Phase 3
Recruiting
Conditions
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Invasive Breast Carcinoma
Interventions
Procedure: Biospecimen Collection
Other: Educational Intervention
Drug: Extended Release Metformin Hydrochloride
Other: Questionnaire Administration
First Posted Date
2025-01-08
Last Posted Date
2025-01-08
Lead Sponsor
City of Hope Medical Center
Target Recruit Count
200
Registration Number
NCT06763328
Locations
🇺🇸

City of Hope Medical Center, Duarte, California, United States

🇺🇸

UC San Diego Moores Cancer Center, La Jolla, California, United States

🇺🇸

University of California-Riverside, Riverside, California, United States

Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes

Phase 2
Not yet recruiting
Conditions
Diabetes
Interventions
First Posted Date
2025-01-07
Last Posted Date
2025-01-07
Lead Sponsor
Mostafa Bahaa
Target Recruit Count
105
Registration Number
NCT06762314
Locations
🇪🇬

Tanta Unuversity, Tanta, Egypt

Inflammation and Insulin Resistance in Obesity

Not yet recruiting
Conditions
Inflammation
Obesity and Type 2 Diabetes
Obesity
Metabolic Syndrome
Anti-Inflammatory Agents
First Posted Date
2024-12-30
Last Posted Date
2025-01-09
Lead Sponsor
University of Aarhus
Target Recruit Count
250
Registration Number
NCT06752018

Weight Reduction with the Low-Insulin-Method - Self Monitoring of Breath Acetone

Not Applicable
Not yet recruiting
Conditions
Overweight and Obese Volunteers
First Posted Date
2024-12-20
Last Posted Date
2024-12-20
Lead Sponsor
West German Center of Diabetes and Health
Target Recruit Count
42
Registration Number
NCT06745362
Locations
🇩🇪

West German Center of Diabetes and Health, Düsseldorf, Germany

© Copyright 2025. All Rights Reserved by MedPath